focus -WSS

focus

author：Wikipedia 2025-09-28 21:58:06 - browse：4796

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

WSS

'Revelatory' study finds a smoking impact that remains after quitting

Readout LOUD podcast: How biotech is using artificial intelligence

At JPM 2024, hospital systems pitch financial strength to investors

Stories you might have missed in 2023: health, science, medicine

Study suggests new cause of Down syndrome: cells linked to aging

Biogen Alzheimer’s drug launch off to slow start

knowledge

focus

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A preacher's new calling: Diversifying neuroscience research

Psychedelics group wrestles with new pharma identity

Industry veterans launch new biotech VC with $310M

Psychedelics group wrestles with new pharma identity

Does Paxlovid work in people vaccinated against Covid

Affirmative action in medical school literally saved lives

Doctors' information doesn't help them choose wisely when sick

Guidelines to prevent youth baseball injuries need more muscle

KalVista pill reduced swelling 'attacks' caused by genetic disease

Wikipedia

How digital tools helped lower hypertension in marginalized patients

Stories you might have missed in 2023: health, science, medicine

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Readout LOUD podcast: How biotech is using artificial intelligence

To avoid data mishandling cases, universities eye AI and other tools

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

entertainment

focus

knowledge

hotspot